Effects of continuous exposure to light on behavioral dopaminergic supersensitivity

Biological Psychiatry

Volumn 45, Issue 12, 1999, Pages 1622-1629

  Abílio, Vanessa C ^a   Freitas, Fábio M ^a   Dolnikoff, Miriam S ^a   Castrucci, Ana Maria L ^b   Filho, Roberto Frussa ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Behavior; Dopamine; Light; Melatonin; Rat; Stress

Indexed keywords

CORTICOSTERONE; DOPAMINE; HALOPERIDOL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DOPAMINERGIC SYSTEM; LIGHT EXPOSURE; MALE; MENTAL STRESS; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; APOMORPHINE; BEHAVIOR, ANIMAL; CORTICOSTERONE; DEXTROAMPHETAMINE; DOPAMINE AGENTS; DOPAMINE AGONISTS; DRUG HYPERSENSITIVITY; HALOPERIDOL; LIGHT; LOCOMOTION; MALE; RATS; RATS, WISTAR; RECEPTORS, PRESYNAPTIC; STEREOTYPIC MOVEMENT DISORDER; TIME FACTORS;

EID: 0344867853     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00305-9     Document Type: Article

References (66)

1. Ahlenius S., Hillegaart V., Thorell G., Magnusson O., Fowler C.J. Suppression of exploratory locomotor activity and increase in dopamine turnover following the application of cis-flupenthixol into limbic projection areas of the rat striatum. Brain Res. 402:1987;131-138.
2. Aldegunde M., Miquez I., Veira J. Effects of pinealectomy on regional brain serotonin. Int J Neurosci. 26:1985;9-13.
3. Al-Khatib I.M.H., Dökmeci I., Fujiwara M. Differential role of nucleus accumbens and caudate-putamen in mediating the effect of nomifensine and methamphetamine on ambulation and rearing of rats in the open-field test. Jpn J Pharmacol. 67:1995;69-77.
4. Anton-Tay F., Chou C., Anton S., Wurtman R.J. Brain serotonin concentration Elevation following intraperitoneal administration of melatonin . Science. 162:1968;277-278.
5. Bernardi M.M., De Souza H., Palermo-Neto J. Effects of single and long-term haloperidol administration on open-field behavior of rats. Psychopharmacol. 73:1981;171-175.
6. Bernardi M.M., Palermo-Neto J. Effects of abrupt and gradual withdrawal from long-term haloperidol treatment on open-field behavior of rats. Psychopharmacol. 65:1979;247-250.
7. Bradbury A.J., Kelly M.E., Smith J.A. Melatonin action in the mid brain can regulate forebrain dopamine function both behaviourally and biochemically. Brown G.M., Wainwright S.D. The Pineal Gland Neuroendocrine Aspects . 1985;327-332 Pergamon Press, Oxford.
8. Brainard G.C., Richardson B.A., King T.S., Matthews S.A., Reiter R.J. The suppression of pineal melatonin content and N-acetyltransferase activity by different light irradiances in the Syrian Hamster A dose-response relationship . Endocrinology. 113:1983;293-296.
9. Broadhurst P.L. Experiments in psychogenetics. Eisink H.J. Experiments in Personality. 1960;Routledge and Kegan Paul, London.
10. Burt D.R., Creese I., Snyder S.H. Antischizophrenic drugs Chronic treatment elevates dopaminergic receptor in brain . Science. 196:1977;326-327.
11. Casey D.E. Tardive dyskinesia - pathophysiology. Bloom F.E., Kupfer D.J. Psychopharmacology The Fourth Generation in Progress . 1995;1497-1502 Raven, New York.
12. Chitkara B., Durcan M.J., Campbell I.C. Apomorphine-induced stereotypy Function of age and rearing environment . Pharmacol Biochem Behav. 21:1984;671-673.
13. Chouinard G., Jones B.D. Neuroleptic-induced supersensitivity psychosis Clinical and pharmacological characteristics . Am J Psychiatry. 137:1980;16-21.
14. Chouinard G., Jones B.D., Annable L. Neuroleptic-induced supersensitivity psychosis. Am J Psychiatry. 135:1978;1409-1410.
15. 3H]Muscimol binding in rat brain. Biochem Pharmacol. 37:1988;1271-1274.
16. Creese I., Iversen S.D. The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Res. 83:1975;419-436.
17. Csernansky J.G., Csernansky C.A., Holliste L.E. Distinct effects of two stresses on the behavioral response to apomorphine. Life Sci. 35:1984;1513-1518.
18. Deroche V., Marinelli M., Maccari S., Moal M.L., Simon H., Piazza P.V. Stress-induced sensitization and glucocorticoids. I Sensitization of dopamine-dependent locomotor effects of amphetamine and morphine depends on stress-induced corticosterone secretion . J Neurosci. 15:1995;7181-7188.
19. Deroche V., Piazza P.V., Casolini P., Le Moal M., Simon H. Sensitization to the psychomotor effects of amphetamine and morphine induced by food restriction depends on stress-induced corticosterone secretion. Brain Res. 611:1993;352-356.
20. Deroche V., Piazza P.V., Casolini P., Maccari S., Le Moal M., Simon H. Stress-induced sensitization to amphetamine and morphine psychomotor effects depends on stress-induced corticosterone secretion. Brain Res. 598:1992;343-348.
21. Deroche V., Piazza P.V., Le Moal M., Simon H. Social isolation-induced enhancement of the psychomotor effects of morphine depends on stress-induced corticosterone secretion. Brain Res. 640:1994;136-139.
22. Deroche V., Piazza P.V., Maccari S., Le Moal M., Simon H. Repeated corticosterone administration sensitizes the locomotor response to amphetamine. Brain Res. 584:1992;309-313.
23. Dewey K.J., Fibiger H.C. The effects of dose and duration of chronic pimozidde administration on dopamine receptor supersensitivity. Naunyn-Schimiedebergs Arch Pharmacol. 322:1983;261-270.
24. Dolnikoff M.S., Kater C.E., Egami M., Senna de Andrade I.S., Marmo M.R. Neonatal treatment with monosodium glutamate increases plasma corticosterone in the rat. Neuroendocrinol. 48:1988;645-649.
25. Ebadi M., Srinivasan S.K. Pathogenesis, prevention, and treatment of neuroleptic-induced movement disorders. Pharmacol Rev. 47:1995;575-604.
26. Ernst A.M. Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia. 10:1967;316-323.
27. Faunt J.E., Crocker A.D. Adrenocortical hormone status affects response to dopamine receptors agonists. Eur J Pharmacol. 152:1988;255-261.
28. Felício L.F., Naselo A.G., Palermo-Neto J. Dopaminergic supersensitivity after long term bromopride treatment. Physiol Behav. 41:1987;433-437.
29. Fleminger S., Rupniak N.M.J., Hall M.D., Jenner P., Marsden C.D. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not increases in D-1 receptors. Biochem Pharmacol. 32:1983;2921-2927.
30. Frussa-Filho R., Abílio V.C., Bergamo M., Palermo-Neto J. Behavioural subsensitivity induced by long-term administration of a low dose of haloperidol to rats. J Pharm Pharmacol. 49:1997;412-415.
31. Frussa-Filho R., Palermo-Neto J. Effects of single and long-term administration of sulpiride on open-field and stereotyped behavior of rats. Braz J Med Biol Res. 23:1990;463-472.
32. Frussa-Filho R., Palermo-Neto J. Effects of single and long-term dropreidol administration on open-field and stereotypical behavior of rats. Physiol Behav. 50:1991;825-830.
33. Frussa-Filho R., Palermo-Neto J. Effects of single and long-term metoclopramide administration on open-field and stereotyped behavior of rats. Eur J Pharmacol. 149:1988;323-329.
34. 3H]catecholamines in the brain of CD-1 mice. Brain Res. 120:1977;571-576.
35. Jackson D.M., Andén N.-E., Dahlström A. A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain. Psychopharmacologia. 45:1975;139-149.
36. Kapur S., Remington G.R. Serotonin-dopamine interactions and its relevance to schizophrenia. Am J Psychiat. 153:1996;466-476.
37. Kelly P.H., Seviour P.W., Iversen S.D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesion of the nucleus accumbens, septi and corpus striatum. Brain Res. 94:1975;507-522.
38. Klawans H.L. The pharmacology of extrapyramidal movement disorders. Cohen M.M. Monographs in Neural Science. 1973;1-37 Karger, Basel.
39. Koop N., Claustrat B., Tappaz M. Evidence for the presence of melatonin in the human brain. Neurosci Lett. 19:1980;237-242.
40. Latimer P.R. Tardive dyskinesia A review . Canad J Psychiat. 40:1995;49S-54S.
41. LeDuc P.A., Mittleman G. Interactions between chronic haloperidol treatment and cocaine in rats An animal model of intermittent cocaine use in neuroleptic treated populations . Psychopharmacol. 110:1993;427-436.
42. Lewy A.J., Wehr T.A., Goodwin F.K., Newsome D.A., Markey S.P. Light supresses melatonin secretion in humans. Science. 210:1980;1267-1269.
43. Martin-Iverson M.T., Iversen S.D. Day and night locomotor activity effects during administration of (+)-amphetamine. Pharmacol Biochem Behav. 34:1989;465-471.
44. Martin-Iverson M.T., Stahl S.M., Iversen S.D. Chronic administration of a selective dopamine D-2 agonist Factors determining behavioral tolerance and sensitization . Psychopharmacol. 95:1988;534-539.
45. Martin-Iverson M.T., Yamada N. Synergistic behavioural effect of dopamine D1 and D2 receptors agonists are determined by circadian rhythms. Eur J Pharmacol. 215:1992;119-125.
46. McIntyre I.M., Norman T.R., Burrows G.D., Armstrong S.M. Human melatonin response to light at different times of the night. Psychoneuroendocrinol. 14:1989;187-193.
47. Monteleone P., Esposito G., La Rocca A., Maj M. Does bright light suppress nocturnal melatonin secretion more in women than in men? J Neur Transm Gen Section. 102:1995;75-80.
48. Moore R.Y., Klein D.C. Visual pathways and the central neural control of a circadian rhythm in pineal serotonin N-acetyltransferase. Brain Res. 71:1974;17-33.
49. Muller P., Seeman P. Dopaminergic supersensitivity after neuroleptics Time course and specificity . Psychopharmacol. 60:1978;1-11.
50. Oller do Nascimento Curi C.M., Ribeiro E.B., Faria C.T.B.V., Dolnikoff M.S. Glycemic response to stress stimulation by ether exposure in adrenalectomized rats. Pharmacol Biochem Behav. 37:1990;399-403.
51. Palermo-Neto J. Supersensitivity, drug withdrawal, and open-field behavior. Psychopharmacol Bull. 18:1982;11-12.
52. Panke E.S., Rollag M.D., Reiter R.J. Pineal melatonin concentration in the Syrian Hamster. Endocrinology. 104:1979;194-197.
53. Queiroz C.M.T., Frussa-Filho R. Effects of buspirone on dopaminergic supersensitivity. Life Sci. 61:1997;371-382.
54. Rao M.L., Miller-Oerlinghausen B., Mackert A., Stieglitz R.D., Strebel B., Volz H.P. The influence of phototherapy on serotonin and melatonin in non-seasonal depression. Pharmacopsychiatry. 23:1990;155-158.
55. Reid M., Herrera-Marschitz M., Ungersted U. Effects of intranigral substance P and neurokinin A on striatal dopamine release-II. Interactions with bicuculine and naloxone. Neuroscience. 36:1990;659-667.
56. Reiter R.J. Action spectra, dose-dependent relationships and temporal aspects of light's effects on the pineal gland. Ann N Y Acad Sci. 453:1985;215-230.
57. Roberts J.E. Visible light induced changes in the immune response through an eye-brain mechanism (photoneuroimmunology). J Photochem Photobiol B:Biol. 29:1995;3-15.
58. Ronken E., Mulder A.H., Schoffelmeer A.N.M. Glucocorticoid and mineralocorticoid receptors differentially modulate cultured dopaminergic neurons of rat ventral mesencephalon. Eur J Pharmacol. 263:1994;149-156.
59. Rudeen P.K., Reiter R.J. Pineal N-acetyltransferase activity in hamsters maintained in shortened light cycles. J Endocrinol Invest. 2:1979;19.
60. Setler P., Sarau H., McKenzie G. Differential attenuation of some effects of haloperidol in rats given scopolamine. Eur J Pharmacol. 39:1976;117-126.
61. Tufik S., Lindsey C.J., Carlini E.A. Does REM sleep deprivation induce a supersensitivity of dopaminergic receptors in the rat brain? Pharmacol. 16:1978;98-105.
62. Veldhuis H.D., de Kloet E.R., Van Zoest I., Bohus B. Adrenalectomy reduces exploratory activity in the rat A specific role of corticosterone . Horm Behav. 16:1982;191-198.
63. Vital M.A.B.F., Frussa-Filho R., Palermo-Neto J. Effects of monosialoganglioside GM1 on dopaminergic supersensitivity. Life Sci. 56:1995;2299-2307.
64. Vital M.A.B.F., Tufik S., Flório J.C., Frussa-Filho R., De Lucia R., Palermo-Neto J. Effects of haloperidol and GM1 ganglioside treatment on striatal D2 receptor binding and dopamine turnover. Life Sci. 62:1998;1161-1169.
65. Williams J.L., Barber G. Effects of cat exposure and cat odors on subsequent amphetamine-induced stereotypy. Pharmacol Biochem Behav. 36:1990;375-380.
66. Wolkowitz O., Sutton M., Koulu M., et al. Chronic corticosterone administration in rats Behavioural and biochemical evidence of increased central dopaminergic activity . Eur J Pharmacol. 122:1986;329-338.